Business Segments · Depreciation
Biopharma Laboratory Services — Depreciation
Labcorp Holdings Biopharma Laboratory Services — Depreciation decreased by 2.7% to $28.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $28.60M to $28.60M. Over 3 years (FY 2022 to FY 2025), Biopharma Laboratory Services — Depreciation shows relatively stable performance with a 0.9% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toD&A
How to read this metric
High depreciation indicates a capital-intensive business model, while changes may reflect shifts in investment cycles for new laboratory technology.
Detailed definition
This represents the systematic allocation of the cost of tangible assets, such as laboratory equipment and facilities, o...
Peer comparison
Standard non-cash expense metric for asset-heavy service businesses.
Metric ID:
lh_segment_biopharma_laboratory_services_depreciationHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.20M | $28.20M | $28.20M | $28.20M | $28.13M | $28.13M | $28.13M | $28.13M | $31.20M | $30.30M | $31.50M | $29.60M | $28.60M | $29.00M | $29.00M | $29.40M | $28.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -0.3% | +0.0% | +0.0% | +0.0% | +10.9% | -2.9% | +4.0% | -6.0% | -3.4% | +1.4% | +0.0% | +1.4% | -2.7% |
| YoY Change | — | — | — | — | -0.3% | -0.3% | -0.3% | -0.3% | +10.9% | +7.7% | +12.0% | +5.2% | -8.3% | -4.3% | -7.9% | -0.7% | +0.0% |
Range$28.13M – $31.50M
CAGR+0.4%
Avg YoY Growth+1.0%
Median YoY Growth-0.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's biopharma laboratory services — depreciation?
- Labcorp Holdings (LH) reported biopharma laboratory services — depreciation of $28.60M in Q1 2026.
- How has Labcorp Holdings's biopharma laboratory services — depreciation changed year-over-year?
- Labcorp Holdings's biopharma laboratory services — depreciation decreased by 0.0% year-over-year, from $28.60M to $28.60M.
- What is the long-term trend for Labcorp Holdings's biopharma laboratory services — depreciation?
- Over 3 years (2022 to 2025), Labcorp Holdings's biopharma laboratory services — depreciation has grown at a 0.9% compound annual growth rate (CAGR), from $112.80M to $116.00M.
- What does biopharma laboratory services — depreciation mean?
- The annual expense recorded for the wear and tear of equipment and facilities in the Biopharma Laboratory Services segment.